Lux Health Technologies Ltd

(Registration number: 10065887)
Balance Sheet as at 31 December 2024

	Note	2024 £	2023 £
Capital and reserves
Called up share capital		10	10
Profit and loss account		(10)	(10)
Total equity		-	-

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised for issue by the director on 10 September 2025
 

.........................................

T H Povlsen
Director

Lux Health Technologies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1	Statutory information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
16 Queen Anne's Gate
London
SW1H 9AA

2	Accounting policies

Summary of significant accounting policies

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention.

The financial statements are prepared in pounds sterling which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

Lux Health Technologies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4	Intangible fixed assets

	Development costs £
Cost
At 1 January 2024	1,389,665
At 31 December 2024	1,389,665
Amortisation
At 1 January 2024	1,389,665
At 31 December 2024	1,389,665
Carrying amount
At 31 December 2024	-

5	Share capital

Allotted, called up and fully paid shares

	2024		2023
	No.	£	No.	£
Ordinary shares of £1 each	10	10	10	10

6	Parent and ultimate parent undertaking

The company's immediate parent is Nine United Properties UK Ltd, a company incorporated in England and Wales.